(Sr.) Director of Value, Access and Policy, Europe

About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA‑approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid‑to‑late‑stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier‑stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference. Position Summary The (Sr.) Director of Value, Access and Policy, Europe, is a key partner on Acadia’s Global Value & Access Team, and on the European Value, Access and Policy team, and has accountability to achieve and maintain appropriate pricing and market access through propositions that deliver value to patients, healthcare sys...